Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Ekso Bionics Holdings (EKSO) over the last 12 years, with Q3 2025 value amounting to -$12000.0.

  • Ekso Bionics Holdings' Cash from Investing Activities fell 5000.0% to -$12000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$83000.0, marking a year-over-year decrease of 4067.8%. This contributed to the annual value of -$37000.0 for FY2024, which is 7643.31% up from last year.
  • Latest data reveals that Ekso Bionics Holdings reported Cash from Investing Activities of -$12000.0 as of Q3 2025, which was down 5000.0% from -$40000.0 recorded in Q2 2025.
  • In the past 5 years, Ekso Bionics Holdings' Cash from Investing Activities registered a high of $1000.0 during Q4 2021, and its lowest value of -$5.0 million during Q4 2022.
  • Moreover, its 5-year median value for Cash from Investing Activities was -$21000.0 (2024), whereas its average is -$417692.3.
  • As far as peak fluctuations go, Ekso Bionics Holdings' Cash from Investing Activities crashed by 50350000.0% in 2022, and later soared by 9914.58% in 2023.
  • Quarter analysis of 5 years shows Ekso Bionics Holdings' Cash from Investing Activities stood at $1000.0 in 2021, then plummeted by 503500.0% to -$5.0 million in 2022, then soared by 99.15% to -$43000.0 in 2023, then soared by 51.16% to -$21000.0 in 2024, then soared by 42.86% to -$12000.0 in 2025.
  • Its Cash from Investing Activities was -$12000.0 in Q3 2025, compared to -$40000.0 in Q2 2025 and -$10000.0 in Q1 2025.